Outcomes Research
EyeBio
Job Description
We aim to become the premier research‑intensive biopharmaceutical company by through the following priorities:
- Investing in, strengthening, and accelerating our pipeline to deliver life‑changing products
- Demonstrating value to stakeholders and expanding access to solutions that address unmet medical needs
- Driving innovation and productivity enabled by digital and data
- Investing in the growth, success, and well‑being of our people
The requesting position develops and executes the Value & Implementation Plan (V&I Plan) for assigned our company assets across some therapeutic areas (no TA specialization required). This role is responsible for generating, synthesizing, and communicating evidence to maximize product value and support market access, pricing, and reimbursement.
Key Responsibilities
- Plan and execute HEOR strategy as the V&I Plan for assigned assets, including value hypotheses, evidence generation, timelines, and implementation
- Conduct a country adaptation of cost‑effectiveness, and budget impact analyses to support pricing and reimbursement and to meet HTA expectations
- Develop core HEOR deliverables:
- Value dossiers and payer evidence materials for Japan HTA
- Economic models (CEA/CUA, budget impact) and model adaptations for Japan
- Systematic/scoping literature reviews and indirect treatment comparisons/NMA
- Retrospective database analyses and real‑world evidence (RWE) studies
- Translate field and payer insights into actionable evidence plans; identify access barriers, demand hurdles, and evidence gaps and propose solutions
- Coordinate cross‑functional collaboration with Medical, Pricing & Market Access, Policy, Clinical Development, and Field/Marketing teams to align on evidence needs and delivery
- Manage external vendors and budgets; ensure methodological rigor, fit‑for‑purpose design, and compliance with relevant guidelines and HTA standards
- Prepare clear, audience‑appropriate communications (slides, summaries, publications) and support internal/external presentations, including payer interactions as needed
Qualifications
Education:
- Doctoral degree from a recognized school of medicine, public health, management, pharmacy, or economics - OR - Master’s Degree required from a recognized school of medicine, public health, life science, pharmacy, or economics.
Required:
- 3 or more years relevant experience in the areas of health economics, outcomes research, epidemiology, market access, HTA or related field
- Strong leadership, project management, and strategic thinking skills
- A track record of scientific presentations and publications
- Business level of English and Japanese
Preferred:
- Good understanding of HTA/reimbursement and market access needs in Japan
Required Skills:
Data Analysis, Epidemiology, Health Economics, Health Outcomes Research, Outcomes Research, Public Health, Stakeholder Relationship Management, Strategic PlanningPreferred Skills:
Current Employees apply HERE
Current Contingent Workers apply HERE
Search Firm Representatives Please Read Carefully
Merck & Co., Inc., Rahway, NJ, USA, also known as Merck Sharp & Dohme LLC, Rahway, NJ, USA, does not accept unsolicited assistance from search firms for employment opportunities. All CVs / resumes submitted by search firms to any employee at our company without a valid written search agreement in place for this position will be deemed the sole property of our company. No fee will be paid in the event a candidate is hired by our company as a result of an agency referral where no pre-existing agreement is in place. Where agency agreements are in place, introductions are position specific. Please, no phone calls or emails.
Employee Status:
RegularRelocation:
VISA Sponsorship:
Travel Requirements:
Flexible Work Arrangements:
HybridShift:
Valid Driving License:
Hazardous Material(s):
Job Posting End Date:
06/30/2026*A job posting is effective until 11:59:59PM on the day BEFORE the listed job posting end date. Please ensure you apply to a job posting no later than the day BEFORE the job posting end date.